Understanding psychological outcomes in cancer: The interplay between hope, dignity, demoralization, and posttraumatic growth.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
112 patients with various types of cancer participated.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSIONS] Enhancing hope and dignity in cancer patients may contribute significantly to reducing demoralization and enhancing posttraumatic growth. There is a need for holistic interventions that take into account the emotional and existential dimensions of cancer.
[PURPOSE] The study investigates the relationship between hope and dignity with demoralization and posttraumatic growth (PTG) in cancer patients.
- 연구 설계 cross sectional
APA
Tsatsou I, Nikoloudi M, et al. (2025). Understanding psychological outcomes in cancer: The interplay between hope, dignity, demoralization, and posttraumatic growth.. European journal of oncology nursing : the official journal of European Oncology Nursing Society, 79, 102984. https://doi.org/10.1016/j.ejon.2025.102984
MLA
Tsatsou I, et al.. "Understanding psychological outcomes in cancer: The interplay between hope, dignity, demoralization, and posttraumatic growth.." European journal of oncology nursing : the official journal of European Oncology Nursing Society, vol. 79, 2025, pp. 102984.
PMID
41016266 ↗
Abstract 한글 요약
[PURPOSE] The study investigates the relationship between hope and dignity with demoralization and posttraumatic growth (PTG) in cancer patients.
[METHODS] Α cross sectional study was conducted with convenience sampling. Participants completed the Hearth Hope Index (HHI), Patient Dignity Inventory (PDI), Demoralization Scale-II (DS-II) and Posttraumatic Growth Inventory (PTGI). Univariate and multivariate linear regressions were performed, taking into account demographic and clinical confounders.
[RESULTS] A total of 112 patients with various types of cancer participated. Mean age of the participants was 66 years and 22.3 % had lung cancer. Hope was found to be negatively correlated to demoralization (r = -0.75, p-value<0.01) and positively correlated to the various factors of PTGI (r = 0.45, p-value<0.01). Then, dignity was positively correlated with demoralization (r = 0.79, p-value<0.01) but negatively correlated with PTGI (r = -0.37, p-value<0.01). Univariate and multivariable linear regression analysis identified a negative relationship between hope and demoralization (adjusted coefficient beta = -0.574, 95 %CI = -0.769 to -0.380, p-value<0.001), a positive association between dignity and demoralization (adjusted coefficient beta = 0.209, 95 %CI = 0.156 to 0.261, p-value<0.001) and negative association between dignity and the factor "new possibilities" of the PTGI (adjusted coefficient beta = -0.070, 95 %CI = -0.116 to -0.024, p-value = 0.003). Finally, hope was associated with increased confrontation (adjusted coefficient beta = 0.258, 95 % CI = 0.047 to 0.469, p-value = 0.017), appreciation of life (adjusted coefficient beta = 0.215, 95 % CI = 0.074 to 0.357, p-value = 0.003), and spiritual change of the PTGI (adjusted coefficient beta = 0.134, 95 %CI = 0.019 to 0.249, p-value = 0.022).
[CONCLUSIONS] Enhancing hope and dignity in cancer patients may contribute significantly to reducing demoralization and enhancing posttraumatic growth. There is a need for holistic interventions that take into account the emotional and existential dimensions of cancer.
[METHODS] Α cross sectional study was conducted with convenience sampling. Participants completed the Hearth Hope Index (HHI), Patient Dignity Inventory (PDI), Demoralization Scale-II (DS-II) and Posttraumatic Growth Inventory (PTGI). Univariate and multivariate linear regressions were performed, taking into account demographic and clinical confounders.
[RESULTS] A total of 112 patients with various types of cancer participated. Mean age of the participants was 66 years and 22.3 % had lung cancer. Hope was found to be negatively correlated to demoralization (r = -0.75, p-value<0.01) and positively correlated to the various factors of PTGI (r = 0.45, p-value<0.01). Then, dignity was positively correlated with demoralization (r = 0.79, p-value<0.01) but negatively correlated with PTGI (r = -0.37, p-value<0.01). Univariate and multivariable linear regression analysis identified a negative relationship between hope and demoralization (adjusted coefficient beta = -0.574, 95 %CI = -0.769 to -0.380, p-value<0.001), a positive association between dignity and demoralization (adjusted coefficient beta = 0.209, 95 %CI = 0.156 to 0.261, p-value<0.001) and negative association between dignity and the factor "new possibilities" of the PTGI (adjusted coefficient beta = -0.070, 95 %CI = -0.116 to -0.024, p-value = 0.003). Finally, hope was associated with increased confrontation (adjusted coefficient beta = 0.258, 95 % CI = 0.047 to 0.469, p-value = 0.017), appreciation of life (adjusted coefficient beta = 0.215, 95 % CI = 0.074 to 0.357, p-value = 0.003), and spiritual change of the PTGI (adjusted coefficient beta = 0.134, 95 %CI = 0.019 to 0.249, p-value = 0.022).
[CONCLUSIONS] Enhancing hope and dignity in cancer patients may contribute significantly to reducing demoralization and enhancing posttraumatic growth. There is a need for holistic interventions that take into account the emotional and existential dimensions of cancer.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.